LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $833,000 | -9.3% | 7,300 | 0.0% | 0.31% | -8.8% |
| Q1 2019 | $918,000 | -84.7% | 7,300 | -87.0% | 0.34% | -90.9% |
| Q4 2018 | $5,998,000 | -18.5% | 56,300 | +60.9% | 3.72% | +6.4% |
| Q3 2018 | $7,363,000 | +1.6% | 35,000 | 0.0% | 3.50% | +25.7% |
| Q2 2018 | $7,250,000 | +4.5% | 35,000 | -16.7% | 2.78% | +2.9% |
| Q1 2018 | $6,936,000 | +74.7% | 42,000 | +44.8% | 2.71% | +93.3% |
| Q4 2017 | $3,971,000 | +0.6% | 29,000 | 0.0% | 1.40% | -8.9% |
| Q3 2017 | $3,946,000 | +261.0% | 29,000 | +222.2% | 1.54% | +270.1% |
| Q2 2017 | $1,093,000 | +14.8% | 9,000 | 0.0% | 0.42% | +14.0% |
| Q1 2017 | $952,000 | -68.8% | 9,000 | -70.0% | 0.36% | -73.5% |
| Q4 2016 | $3,048,000 | – | 30,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |